Bob Labick - CJS Securities, Inc. Greetings, and welcome to the ACV Q1 2026 Earnings Conference Call Webcast. [Operator Instructions]. As a reminder, this conference is being recorded. It's now my ...
A phase II study to evaluate the effects of docetaxel plus lycopene in advanced castrate-resistant prostate cancer. Rucaparib plus enzalutamide in patients (pts) with metastatic castration-resistant ...
Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
There are lots of reasons walking workouts are so popular. Walking boasts all the health and fitness benefits of other low-intensity steady-state cardio (LISS) workouts. Plus, they’re convenient and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results